THE ULTIMATE GUIDE TO MBO128

Emily Bodnar’s ranking is predicated on the anticipation of major milestones for Agenus in the coming 12 months, particularly the likely filing of the Biologics License Application (BLA) for their direct drug candidate, botensilimab (bot). Agenus has dosed above 900 sufferers with bot throughout many good tumors, exhibiting a motivation to intens